{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:56Z","timestamp":1785757616509,"version":"3.56.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011696","name":"shahed University","doi-asserted-by":"crossref","award":["522458"],"award-info":[{"award-number":["522458"]}],"id":[{"id":"10.13039\/501100011696","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54103-0","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T16:42:37Z","timestamp":1779640957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pioglitazone protects against trimethyltin hippocampal injury by reducing pyroptosis, mitochondrial dysregulation and ER stress"],"prefix":"10.1038","volume":"16","author":[{"given":"Nasim","family":"Abaspour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"key":"54103_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared, A. A., Byrnes, M. J., White, L. A. & Zhang, Q. Alzheimer\u2019s Disease: Epidemiology and Clinical Progression. Neurol. Ther. 11, 553\u2013569 (2022).","journal-title":"Neurol. Ther."},{"key":"54103_CR2","doi-asserted-by":"crossref","unstructured":"Rujeedawa, T., Carrillo F\u00e9lez, E., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A. S., Coppus, A., Levin, J. & Zaman, S. H. 2021. The clinical and neuropathological features of sporadic (late-onset) and genetic forms of alzheimer\u2019s disease. J Clin Med, 10.","DOI":"10.3390\/jcm10194582"},{"key":"54103_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810572","author":"NF Al-Ghraiybah","year":"2022","unstructured":"Al-Ghraiybah, N. F. et al. Glial cell-mediated neuroinflammation in Alzheimer\u2019s Disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms231810572 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"54103_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05153-5","volume":"13","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady, A., Lindholm, D., Ren, J. & Pratico, D. ER stress and UPR in Alzheimer\u2019s disease: Mechanisms, pathogenesis, treatments. Cell Death Dis 13, 706 (2022).","journal-title":"Cell Death Dis"},{"key":"54103_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","volume":"20","author":"S Bhatia","year":"2022","unstructured":"Bhatia, S. et al. Mitochondrial dysfunction in Alzheimer\u2019s disease: Opportunities for drug development. Curr Neuropharmacol 20, 675\u2013692 (2022).","journal-title":"Curr Neuropharmacol"},{"key":"54103_CR6","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.4103\/1673-5374.391311","volume":"19","author":"B Hu","year":"2024","unstructured":"Hu, B. et al. NLRP3\/1-mediated pyroptosis: Beneficial clues for the development of novel therapies for Alzheimer\u2019s disease. Neural Regen. Res. 19, 2400\u20132410 (2024).","journal-title":"Neural Regen. Res."},{"key":"54103_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111382","volume":"227","author":"Z Asgari","year":"2025","unstructured":"Asgari, Z., Iranzadeh, S. & Roghani, M. Myricetin alleviates learning and memory deficits in trimethyltin Alzheimer\u2019s phenotype via attenuating hippocampal endoplasmic reticulum stress and regulating inflammation and oxidative stress. Brain Res Bull 227, 111382 (2025).","journal-title":"Brain Res Bull"},{"key":"54103_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/019262338701500102","volume":"15","author":"DG Robertson","year":"1987","unstructured":"Robertson, D. G., Gray, R. H. & DE LA Iglesia, F. A. Quantitative assessment of trimethyltin induced pathology of the hippocampus. Toxicol. Pathol. 15, 7\u201317 (1987).","journal-title":"Toxicol. Pathol."},{"key":"54103_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neuint.2011.03.009","volume":"58","author":"MC Geloso","year":"2011","unstructured":"Geloso, M. C., Corvino, V. & Michetti, F. Trimethyltin-induced hippocampal degeneration as a tool to investigate neurodegenerative processes. Neurochem. Int. 58, 729\u2013738 (2011).","journal-title":"Neurochem. Int."},{"key":"54103_CR10","doi-asserted-by":"crossref","unstructured":"Faryadras, K., Golchoobian, R., Iranzadeh, S. & Roghani, M. 2025. Promising neuroprotective potential of naringenin against trimethyltin-induced cognitive deficits and hippocampal neurodegeneration in rats. Frontiers in Neuroscience, Volume 19 - 2025.","DOI":"10.3389\/fnins.2025.1567236"},{"key":"54103_CR11","doi-asserted-by":"crossref","unstructured":"Jeong, E. S., Bajgai, J., You, I. S., Rahman, M. H., Fadriquela, A., Sharma, S., Kwon, H. U., Lee, S. Y., Kim, C. S. & Lee, K. J. 2021. Therapeutic Effects of Hydrogen Gas Inhalation on Trimethyltin-Induced Neurotoxicity and Cognitive Impairment in the C57BL\/6 Mice Model. Int J Mol Sci, 22.","DOI":"10.3390\/ijms222413313"},{"key":"54103_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova, L. D. et al. Mitochondrial membrane potential. Anal. Biochem. 552, 50\u201359 (2018).","journal-title":"Anal. Biochem."},{"key":"54103_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2022.109505","volume":"263","author":"H Zhu","year":"2023","unstructured":"Zhu, H. et al. ROS\/ER stress contributes to trimethyltin chloride-mediated hepatotoxicity; tea polyphenols alleviate apoptosis and immunosuppression. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 263, 109505 (2023).","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"54103_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/735206","volume":"2012","author":"E Ferreiro","year":"2012","unstructured":"Ferreiro, E. et al. Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer\u2019s disease: From pathogenesis to biomarkers. Int. J. Cell Biol. 2012, 735206 (2012).","journal-title":"Int. J. Cell Biol."},{"key":"54103_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112167","volume":"11","author":"MC Jurc\u0103u","year":"2022","unstructured":"Jurc\u0103u, M. C. et al. The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: Therapeutic implications and future perspectives. Antioxidants 11, 2167 (2022).","journal-title":"Antioxidants"},{"key":"54103_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01515-4","volume":"40","author":"A Salari","year":"2024","unstructured":"Salari, A., Roghani, M. & Khalili, M. HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer\u2019s-associated markers. Metab. Brain Dis. 40, 74 (2024).","journal-title":"Metab. Brain Dis."},{"key":"54103_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10571-024-01502-4","volume":"44","author":"M Taheri","year":"2024","unstructured":"Taheri, M., Roghani, M. & Sedaghat, R. Metformin mitigates Trimethyltin-induced cognition impairment and hippocampal neurodegeneration. Cell. Mol. Neurobiol. 44, 70 (2024).","journal-title":"Cell. Mol. Neurobiol."},{"key":"54103_CR18","doi-asserted-by":"crossref","unstructured":"Mohanty, P. K. & Patel, R. 2025. Central role of PPAR\u03b3 in Alzheimer\u2019s disease: From pathophysiology to potential therapies. AN.","DOI":"10.36922\/an.6479"},{"key":"54103_CR19","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","volume":"45","author":"S W\u00f3jtowicz","year":"2020","unstructured":"W\u00f3jtowicz, S., Strosznajder, A. K., Je\u017cyna, M. & Strosznajder, J. B. The novel role of PPAR Alpha in the brain: Promising target in therapy of Alzheimer\u2019s Disease and other neurodegenerative disorders. Neurochem. Res. 45, 972\u2013988 (2020).","journal-title":"Neurochem. Res."},{"key":"54103_CR20","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.2147\/DDDT.S367229","volume":"16","author":"A Alhowail","year":"2022","unstructured":"Alhowail, A., Alsikhan, R., Alsaud, M., Aldubayan, M. & Rabbani, S. I. Protective effects of Pioglitazone on cognitive impairment and the underlying mechanisms: A review of literature. Drug Des Devel Ther 16, 2919\u20132931 (2022).","journal-title":"Drug Des Devel Ther"},{"key":"54103_CR21","first-page":"940","volume":"22","author":"F Beheshti","year":"2019","unstructured":"Beheshti, F. et al. The effects of PPAR-\u03b3 agonist pioglitazone on hippocampal cytokines, brain-derived neurotrophic factor, memory impairment, and oxidative stress status in lipopolysaccharide-treated rats. Iran J Basic Med Sci 22, 940\u2013948 (2019).","journal-title":"Iran J Basic Med Sci"},{"key":"54103_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3233\/JAD-190026","volume":"71","author":"Q Quan","year":"2019","unstructured":"Quan, Q., Qian, Y., Li, X. & Li, M. CDK5 participates in Amyloid-\u03b2 production by regulating PPAR\u03b3 phosphorylation in primary rat hippocampal neurons. J. Alzheimers Dis. 71, 443\u2013460 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"54103_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00178","volume":"11","author":"Q Quan","year":"2019","unstructured":"Quan, Q., Qian, Y., Li, X. & Li, M. Pioglitazone reduces beta amyloid levels via inhibition of PPARgamma phosphorylation in a neuronal model of Alzheimer\u2019s disease. Front. Aging Neurosci. 11, 178 (2019b).","journal-title":"Front. Aging Neurosci."},{"key":"54103_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109793","volume":"97","author":"N Assaf","year":"2020","unstructured":"Assaf, N., El-Shamarka, M. E., Salem, N. A., Khadrawy, Y. A. & El Sayed, N. S. Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt\/beta catenin pathway via targeting alpha- and beta-secretases. Prog Neuropsychopharmacol Biol Psychiatry 97, 109793 (2020).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"54103_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1742-2094-8-91","volume":"8","author":"CR Swanson","year":"2011","unstructured":"Swanson, C. R. et al. The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in Parkinsonian monkeys. J. Neuroinflammation 8, 91 (2011).","journal-title":"J. Neuroinflammation"},{"key":"54103_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.70109","author":"J Luo","year":"2025","unstructured":"Luo, J. et al. Pioglitazone ameliorates mitochondrial oxidative stress and inflammation via AMPK-dependent inhibition of mitochondrial fission in Leigh Syndrome. Cell Prolif. https:\/\/doi.org\/10.1111\/cpr.70109 (2025).","journal-title":"Cell Prolif."},{"key":"54103_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114714","volume":"457","author":"AH Alhowail","year":"2024","unstructured":"Alhowail, A. H. Pioglitazone ameliorates DOX-induced cognitive impairment by mitigating inflammation, oxidative stress, and apoptosis of hippocampal neurons in rats. Behav. Brain Res. 457, 114714 (2024).","journal-title":"Behav. Brain Res."},{"key":"54103_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4062\/biomolther.2014.146","volume":"23","author":"CH Lee","year":"2015","unstructured":"Lee, C. H. et al. Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampus. Biomol Ther (Seoul) 23, 261\u20137 (2015).","journal-title":"Biomol Ther (Seoul)"},{"key":"54103_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112781","author":"GHO Da Rocha","year":"2022","unstructured":"Da Rocha, G. H. O. et al. Pioglitazone attenuates the effects of peripheral inflammation in a human in vitro blood-brain barrier model. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232112781 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"54103_CR30","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s12031-022-02021-x","volume":"72","author":"A Rostami","year":"2022","unstructured":"Rostami, A. et al. Sinomenine attenuates trimethyltin-induced cognitive decline via targeting hippocampal oxidative stress and neuroinflammation. J. Mol. Neurosci. 72, 1609\u20131621 (2022).","journal-title":"J. Mol. Neurosci."},{"key":"54103_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111734","volume":"140","author":"YY Lam","year":"2021","unstructured":"Lam, Y. Y., Tsai, S. F., Chen, P. C., Kuo, Y. M. & Chen, Y. W. Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice.. Biomed. Pharmacother. 140, 111734 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"54103_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/FBP.0000000000000407","volume":"30","author":"ST Ekladious","year":"2019","unstructured":"Ekladious, S. T. & El Sayed, N. S. Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: Possible role of glutamatergic pathway and oxidative stress. Behav. Pharmacol. 30, 5\u201315 (2019).","journal-title":"Behav. Pharmacol."},{"key":"54103_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/fcp.12585","volume":"35","author":"AA Gomaa","year":"2021","unstructured":"Gomaa, A. A. et al. Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats. Fundam. Clin. Pharmacol. 35, 97\u2013112 (2021).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"54103_CR34","doi-asserted-by":"publisher","DOI":"10.21769\/bioprotoc.2744","author":"MW Pitts","year":"2018","unstructured":"Pitts, M. W. Barnes maze procedure for spatial learning and memory in mice. Bio Protoc. https:\/\/doi.org\/10.21769\/bioprotoc.2744 (2018).","journal-title":"Bio Protoc."},{"key":"54103_CR35","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/nprot.2013.155","volume":"8","author":"M Leger","year":"2013","unstructured":"Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531\u20132537 (2013).","journal-title":"Nat. Protoc."},{"key":"54103_CR36","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s11011-023-01170-1","volume":"38","author":"M Khaleghi-Mehr","year":"2023","unstructured":"Khaleghi-Mehr, M., Delshad, A. A., Shafie-Damavandi, S. & Roghani, M. Metformin mitigates amyloid \u03b2(1-40)-induced cognitive decline via attenuation of oxidative\/nitrosative stress and neuroinflammation. Metab. Brain Dis. 38, 1127\u20131142 (2023).","journal-title":"Metab. Brain Dis."},{"key":"54103_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01607","volume":"10","author":"C Zou","year":"2019","unstructured":"Zou, C. et al. Pioglitazone attenuates reoxygenation injury in renal tubular NRK-52E cells exposed to high glucose via inhibiting oxidative stress and endoplasmic reticulum stress. Front. Pharmacol. 10, 1607 (2019).","journal-title":"Front. Pharmacol."},{"key":"54103_CR38","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s11011-023-01227-1","volume":"38","author":"E Zahedi","year":"2023","unstructured":"Zahedi, E., Sadr, S. S., Sanaeierad, A. & Roghani, M. Valproate-induced murine autism spectrum disorder is associated with dysfunction of amygdala parvalbumin interneurons and downregulation of AMPK\/SIRT1\/PGC1\u03b1 signaling. Metab. Brain Dis. 38, 2093\u20132103 (2023).","journal-title":"Metab. Brain Dis."},{"key":"54103_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0014-2999(03)01487-0","volume":"465","author":"K Isomae","year":"2003","unstructured":"Isomae, K., Morimoto, S., Hasegawa, H., Morita, K. & Kamei, J. Effects of T-82, a novel acetylcholinesterase inhibitor, on impaired learning and memory in passive avoidance task in rats. Eur. J. Pharmacol. 465, 97\u2013103 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"54103_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fphys.2020.00433","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen, S., Chen, H., Du, Q. & Shen, J. Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: Potential application of natural compounds. Front. Physiol. 11, 433 (2020).","journal-title":"Front. Physiol."},{"key":"54103_CR41","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4758","volume":"13","author":"N Hanning","year":"2023","unstructured":"Hanning, N., DE Man, J. G. & DE Winter, B. Y. Measuring myeloperoxidase activity as a marker of inflammation in gut tissue samples of mice and rat. BIO-PROTOCOL 13, e4758 (2023).","journal-title":"BIO-PROTOCOL"},{"key":"54103_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.nbd.2006.11.003","volume":"25","author":"M Sifringer","year":"2007","unstructured":"Sifringer, M. et al. Activation of caspase-1 dependent interleukins in developmental brain trauma. Neurobiol. Dis. 25, 614\u2013622 (2007).","journal-title":"Neurobiol. Dis."},{"key":"54103_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249102","volume":"16","author":"MSC Sep","year":"2021","unstructured":"Sep, M. S. C., Vellinga, M., Sarabdjitsingh, R. A. & Jo\u00ebls, M. The rodent object-in-context task: A systematic review and meta-analysis of important variables. PLoS One. 16, e0249102 (2021).","journal-title":"PLoS One."},{"key":"54103_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23041","volume":"36","author":"G Pakravan","year":"2022","unstructured":"Pakravan, G. et al. Antiapoptotic and anti-inflammatory effects of Ppar\u03b3 agonist, pioglitazone, reversed Dox-induced cardiotoxicity through mediating of miR-130a downregulation in C57BL\/6 mice. J. Biochem. Mol. Toxicol. 36, e23041 (2022).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"54103_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","volume":"82","author":"BE Ekundayo","year":"2024","unstructured":"Ekundayo, B. E. et al. Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s Disease. Cell Biochem. Biophys. 82, 457\u2013477 (2024).","journal-title":"Cell Biochem. Biophys."},{"key":"54103_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121983","volume":"330","author":"P Nagar","year":"2023","unstructured":"Nagar, P. et al. Endoplasmic reticulum stress in Alzheimer\u2019s disease: Molecular mechanisms and therapeutic prospects. Life Sci. 330, 121983 (2023).","journal-title":"Life Sci."},{"key":"54103_CR47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/ars.2014.5851","volume":"21","author":"SS Cao","year":"2014","unstructured":"Cao, S. S. & Kaufman, R. J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal 21, 396\u2013413 (2014).","journal-title":"Antioxid Redox Signal"},{"key":"54103_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.37349\/edd.2023.00020","volume":"2","author":"H Wu","year":"2023","unstructured":"Wu, H., Bao, X., Gutierrez, A. H., Nevzorova, Y. A. & Cubero, F. J. Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury. Explor. Dig. Dis. 2, 83\u201399 (2023).","journal-title":"Explor. Dig. Dis."},{"key":"54103_CR49","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00109-021-02065-3","volume":"99","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by PI3K\/Akt and Nrf2\/ARE pathways. J Mol Med (Berl) 99, 1073\u20131083 (2021).","journal-title":"J Mol Med (Berl)"},{"key":"54103_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117047","volume":"239","author":"E Soliman","year":"2019","unstructured":"Soliman, E., Behairy, S. F., El-Maraghy, N. N. & Elshazly, S. M. PPAR-\u03b3 agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats. Life Sci. 239, 117047 (2019).","journal-title":"Life Sci."},{"key":"54103_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/ppar\/9645836","volume":"2025","author":"E Civelek","year":"2025","unstructured":"Civelek, E., Karaman, E. F., \u00d6zden, S., Uyde\u015f Do\u011fan, B. S. & Kaleli Durman, D. Effect of pioglitazone on endoplasmic reticulum stress and autophagy response in the perivascular adipose tissue of type 2 diabetic rats. PPAR Res. 2025, 9645836 (2025).","journal-title":"PPAR Res."},{"key":"54103_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.gendis.2019.05.002","volume":"7","author":"Y Deng","year":"2020","unstructured":"Deng, Y. et al. Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPAR\u03b3\/NF-\u03baB\/IL-6 signaling pathway. Genes Dis. 7, 253\u2013265 (2020).","journal-title":"Genes Dis."},{"key":"54103_CR53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2019.05.003","volume":"1718","author":"J Long","year":"2019","unstructured":"Long, J. et al. NLRP3 inflammasome activation is involved in trimethyltin-induced neuroinflammation. Brain Res. 1718, 186\u2013193 (2019).","journal-title":"Brain Res."},{"key":"54103_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112757","volume":"139","author":"AH Shehata","year":"2024","unstructured":"Shehata, A. H. et al. Pioglitazone ameliorates sepsis-associated encephalopathy through SIRT1 signaling pathway. Int. Immunopharmacol. 139, 112757 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"54103_CR55","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.pharep.2018.11.005","volume":"71","author":"MMF Machado","year":"2019","unstructured":"Machado, M. M. F. et al. PPAR-\u03b3 agonist pioglitazone reduces microglial proliferation and NF-\u03baB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson\u2019s disease. Pharmacol. Rep. 71, 556\u2013564 (2019).","journal-title":"Pharmacol. Rep."},{"key":"54103_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126306","volume":"22","author":"J-H Yeh","year":"2021","unstructured":"Yeh, J.-H. et al. Pioglitazone ameliorates lipopolysaccharide-induced behavioral impairment, brain inflammation, white matter injury and mitochondrial dysfunction in neonatal rats. Int. J. Mol. Sci. 22, 6306 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"54103_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-0032-1333277","volume":"121","author":"SH Hu","year":"2013","unstructured":"Hu, S. H., Jiang, T., Yang, S. S. & Yang, Y. Pioglitazone ameliorates intracerebral insulin resistance and tau-protein hyperphosphorylation in rats with type 2 diabetes.. Exp. Clin. Endocrinol. Diabetes 121, 220\u2013224 (2013).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"54103_CR58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-2012-111661","volume":"30","author":"JL Searcy","year":"2012","unstructured":"Searcy, J. L. et al. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 30, 943\u201361 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"54103_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/11795735211029113","volume":"13","author":"I Vecchio","year":"2021","unstructured":"Vecchio, I., Sorrentino, L., Paoletti, A., Marra, R. & Arbitrio, M. The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer\u2019s Disease. J. Cent. Nerv. Syst. Dis. 13, 11795735211029113 (2021).","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"54103_CR60","doi-asserted-by":"publisher","first-page":"10221","DOI":"10.1007\/s00210-025-03895-5","volume":"398","author":"A Rajabian","year":"2025","unstructured":"Rajabian, A. et al. Pioglitazone improves learning and memory in a rat model of cholinergic dysfunction induced by scopolamine, the roles of oxidative stress and neuroinflammation. Naunyn Schmiedebergs Arch. Pharmacol. 398, 10221\u201310237 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"54103_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen, M. M., Borrowman, S. H., Pearce, C., Pyles, B. & Chandra, B. Mitochondrial dysfunction in neurodegenerative disorders.. Neurotherapeutics 21, e00292 (2024).","journal-title":"Neurotherapeutics"},{"key":"54103_CR62","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh, O., Arroum, T., Morris, S. & Busch, K. B. 2023. PGC-1\u03b1 Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel), 12.","DOI":"10.3390\/antiox12051075"},{"key":"54103_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona, J. C. & Duchen, M. R. PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic. Biol. Med. 100, 153\u2013163 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"54103_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.toxlet.2021.04.008","volume":"345","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. The main mechanisms of trimethyltin chloride-induced neurotoxicity: Energy metabolism disorder and peroxidation damage. Toxicol. Lett. 345, 67\u201376 (2021).","journal-title":"Toxicol. Lett."},{"key":"54103_CR65","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.7150\/ijbs.98387","volume":"20","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. PPAR\u03b3 agonist pioglitazone prevents hypoxia-induced cardiac dysfunction by reprogramming glucose metabolism. Int. J. Biol. Sci. 20, 4297\u20134313 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"54103_CR66","doi-asserted-by":"crossref","unstructured":"Xi, L., Sun, H., Yang, N., Wang, Q., Zhang, L., Song, J., Taiwaikuli, D., Shang, L. & Zhou, X. H. 2024. Pioglitazone Alleviates \u03b21-Adrenergic Receptor Antibody-Induced Atrial Fibrillation Susceptivity via Mitigation of PPAR-\u03b3-Mediated Metabolic Inflexibility. Curr Med Chem.","DOI":"10.2174\/0109298673308673240527092317"},{"key":"54103_CR67","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1536\/ihj.21-404","volume":"63","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Huang, C., Zhang, D. & Zhu, Y. Pioglitazone protects against hypoxia-induced cardiomyocyte apoptosis through inhibiting NLRP3\/Caspase-1 pathway in vivo and in vitro. Int. Heart J. 63, 893\u2013903 (2022).","journal-title":"Int. Heart J."},{"key":"54103_CR68","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00280-013-2084-2","volume":"71","author":"C Grommes","year":"2013","unstructured":"Grommes, C. et al. The PPAR\u03b3 agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model. Cancer Chemother. Pharmacol. 71, 929\u201336 (2013).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"54103_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117973","volume":"10","author":"DG Crenshaw","year":"2015","unstructured":"Crenshaw, D. G. et al. Effects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain. PLoS One 10, e0117973 (2015).","journal-title":"PLoS One"},{"key":"54103_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainresbull.2016.07.010","volume":"125","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. Trimethyltin-induced hippocampal neurodegeneration: A mechanism-based review. Brain Res. Bull. 125, 187\u2013199 (2016).","journal-title":"Brain Res. Bull."},{"key":"54103_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh, T., Swerdlow, R. H. & Beal, M. F. The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement 19, 333\u2013342 (2023).","journal-title":"Alzheimers Dement"},{"key":"54103_CR72","first-page":"169","volume":"9","author":"K Khan","year":"2024","unstructured":"Khan, K., Emad, N. A. & Sultana, Y. Inducing agents for Alzheimer\u2019s Disease in animal models. J. Explor. Res. Pharmacol. 9, 169\u2013179 (2024).","journal-title":"J. Explor. Res. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54103-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54103-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54103-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:04:52Z","timestamp":1785755092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54103-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54103"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54103-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23764"}}